)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Isofol Medical
Isofol Medical (ISOFOL) investor relations material
Isofol Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary18 Feb, 2026
Executive summary
Ongoing phase Ib/II clinical study of arfolitixorin in metastatic colorectal cancer, with presentations at major oncology conferences (ESMO, ASCO-GI) highlighting study design and recruitment status.
European Patent Office granted new product patent for arfolitixorin, securing protection until 2043.
Strategic collaboration with Solasia Pharma K.K. to expand clinical studies into Japan, broadening patient diversity and regulatory reach.
Financial highlights
Net revenue was SEK 0 for both Q4 and full year 2025, unchanged from 2024.
Q4 2025 net loss was SEK -12.8 million, a slight improvement from SEK -13.1 million in Q4 2024.
Full year 2025 net loss increased to SEK -54.2 million from SEK -43.5 million in 2024.
Cash and cash equivalents at year-end were SEK 127.0 million, up from SEK 96.2 million, supported by a SEK 84.1 million rights issue.
Equity at year-end was SEK 107.9 million, up from SEK 77.9 million.
Outlook and guidance
Phase II study of arfolitixorin expected to begin later in 2026, with further study updates anticipated in Q1 2026.
Continued focus on advancing arfolitixorin, regulatory interactions, and strategic partnerships, with multiple milestones expected in 2026.
Board proposes no dividend for 2025.
Phase Ib 300 mg/m² dose efficacy outlook
Funding strategy beyond 12 months
Arfolitixorin's broader partnership strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Isofol Medical earnings date
Life Science-dagen 20264 Mar, 2026
Isofol Medical
Next Isofol Medical earnings date
Life Science-dagen 20264 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Isofol Medical is a biopharmaceutical company developing oncology treatments. It focuses on improving existing chemotherapy-based therapies with novel formulations to enhance effectiveness and reduce side effects. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage